Late-phase investigational approaches for the treatment of relapsed/refractory acute myeloid leukemia

Author： Jamieson Katarzyna   Odenike Olatoyosi  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.15, 2012-10, pp. : 2171-2187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relapsed or Refractory Pediatric Acute Lymphoblastic Leukemia: Current and Emerging Treatments

By Martin Alissa   Morgan Elaine   Hijiya Nobuko  

Pediatric Drugs, Vol. 14, Iss. 6, 2012-12 ,pp. : 377-387

Adis International

Access to resources Recommend Favorite

New therapeutic approaches to acute myeloid leukemia

By Uchida Hideo   Inokuchi Koiti   Watanabe Reiko   Tokuhira Michihide   Kizaki Masahiro  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 6, 2008-06 ,pp. : 689-706

Informa Healthcare

Access to resources Recommend Favorite

Potential Therapeutic Approaches for the Treatment of Acute Myeloid Leukemia with AML1-ETO Translocation

By  

Current Cancer Drug Targets, Vol. 16, Iss. 3, 2016-03 ,pp. : 215-225

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Raf Kinase in the Treatment of Acute Myeloid Leukemia

By  

Current Pharmaceutical Design, Vol. 8, Iss. 25, 2002-11 ,pp. : 2243-2248

Bentham Science Publishers

Access to resources Recommend Favorite

The role of quizartinib in the treatment of acute myeloid leukemia

By Ostronoff Fabiana   Estey Elihu  

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 12, 2013-12 ,pp. : 1659-1669

Informa Healthcare

Access to resources Recommend Favorite